Company profile for Mestag Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We aim to do this by leading the field in discovering, developing and delivering impactful precision medicines through unparalleled insight into disease-driving fibroblast subpopulations. Fibroblasts are a type of cell present in many different tissues in the body; recent data point to them as being important drivers of disease. Our Founder team are world-leaders in the field and have identified exciting new biology, opening...
We aim to do this by leading the field in discovering, developing and delivering impactful precision medicines through unparalleled insight into disease-driving fibroblast subpopulations. Fibroblasts are a type of cell present in many different tissues in the body; recent data point to them as being important drivers of disease. Our Founder team are world-leaders in the field and have identified exciting new biology, opening up new therapeutic approaches. Mestag’s team of drug discovery experts is passionate about developing impactful new therapeutics for patients with cancer and inflammatory disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Suites 15&16 Science Village, Chesterford Research Park, Little Chesterford, C...
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2025/03/04/3036436/0/en/Mestag-Therapeutics-Appoints-Dr-Matthew-Sleeman-as-Chief-Scientific-Officer.html

GLOBENEWSWIRE
04 Mar 2025

https://www.globenewswire.com/news-release/2024/12/09/2993724/0/en/Mestag-Therapeutics-Announces-Licensing-of-a-Novel-Inflammatory-Disease-Target-from-its-RAFT-Platform.html

GLOBENEWSWIRE
09 Dec 2024

https://www.globenewswire.com/news-release/2024/11/13/2980224/0/en/Mestag-Therapeutics-Expands-Leadership-Team-and-Appoints-Head-of-Development-and-General-Counsel.html

GLOBENEWSWIRE
13 Nov 2024

https://www.fiercebiotech.com/biotech/merck-signs-19b-deal-mestag-explore-fibroblast-therapies-inflammation

FIERCE BIOTECH
09 Oct 2024

https://www.globenewswire.com/en/news-release/2024/10/08/2959535/0/en/Mestag-Therapeutics-Announces-License-and-Research-Collaboration-with-MSD-to-Identify-Novel-Targets-for-Inflammatory-Diseases.html

GLOBENEWSWIRE
08 Oct 2024

https://www.pharmabiz.com/NewsDetails.aspx?aid=172165&sid=2

PHARMABIZ
29 Aug 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty